Cargando…
New Trends for Antimalarial Drugs: Synergism between Antineoplastics and Antimalarials on Breast Cancer Cells
Chemotherapy plays a key role in breast cancer therapy, but drug resistance and unwanted side effects make the treatment less effective. We propose a new combination model that combines antineoplastic drugs and antimalarials for breast cancer therapy. Cytotoxic effects of two antineoplastic agents a...
Autores principales: | Duarte, Diana, Vale, Nuno |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7761440/ https://www.ncbi.nlm.nih.gov/pubmed/33271968 http://dx.doi.org/10.3390/biom10121623 |
Ejemplares similares
-
Combination of Antimalarial and CNS Drugs with Antineoplastic Agents in MCF-7 Breast and HT-29 Colon Cancer Cells: Biosafety Evaluation and Mechanism of Action
por: Duarte, Diana, et al.
Publicado: (2022) -
Antimicrobial peptides: a new class of antimalarial drugs?
por: Vale, Nuno, et al.
Publicado: (2014) -
Prediction of Drug Synergism between Peptides and Antineoplastic Drugs Paclitaxel, 5-Fluorouracil, and Doxorubicin Using In Silico Approaches
por: Vale, Nuno, et al.
Publicado: (2022) -
The Candidate Antimalarial Drug MMV665909 Causes Oxygen-Dependent mRNA Mistranslation and Synergizes with Quinoline-Derived Antimalarials
por: Vallières, Cindy, et al.
Publicado: (2017) -
Trends in Antimalarial Drug Use in Africa
por: Flegg, Jennifer A., et al.
Publicado: (2013)